Genetics of Lipid Lowering Drugs and Diet Network

Institution(s): 
University of Alabama
Approx. Sample Size to be Sequenced: 
967
Populations: 

European families

Project:

Disease/Phenotype: 

Lipids, omics, dietary intervention

PI: 
Donna K Arnett
NIH Program Officer: 
Starting Phase: 
Phase 2
Phases Involved: 
2
Phenotype Liaison: 
Data Set contact(s): 
Short Name: 
GOLDN
Sequencing Center(s) Phase 2: 
Northwest Genomics Center
Type of Sequencing: 
WGS
Sequencing External Funding: 
TOPMed Accession #: